khaspert
Contributor
Does anyone out there have any experience with using drugs that need intensive monitoring to support a high level of risk in the risk portion of MDM. For example, coumadin is a drug that my physicians have identified as one that needs intensive monitoring. Would you always choose "high risk" in the MDM when a patient comes in who is on coumadin and the your physician is the one monitoring it?
Kim
Kim